C07C 235/58
With carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in
Official title: with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
C07C235/58 (With carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in) appears on 514 US grants and 503 published applications in this corpus.
Search patents in C07C- Granted patents
- 514
- Published applications
- 503
- Assignees
- 319
- Inventors
- 1,672
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 3 | 0 |
| 1992 | 7 | 0 |
| 1993 | 3 | 0 |
| 1994 | 4 | 0 |
| 1995 | 14 | 0 |
| 1996 | 12 | 0 |
| 1997 | 12 | 0 |
| 1998 | 22 | 0 |
| 1999 | 25 | 0 |
| 2000 | 12 | 0 |
| 2001 | 23 | 6 |
| 2002 | 23 | 18 |
| 2003 | 25 | 26 |
| 2004 | 13 | 26 |
| 2005 | 11 | 39 |
| 2006 | 16 | 23 |
| 2007 | 19 | 23 |
| 2008 | 21 | 21 |
| 2009 | 14 | 26 |
| 2010 | 19 | 26 |
| 2011 | 12 | 17 |
| 2012 | 18 | 15 |
| 2013 | 18 | 22 |
| 2014 | 16 | 23 |
| 2015 | 12 | 28 |
| 2016 | 19 | 21 |
| 2017 | 14 | 23 |
| 2018 | 18 | 10 |
| 2019 | 10 | 11 |
| 2020 | 8 | 15 |
| 2021 | 14 | 23 |
| 2022 | 13 | 18 |
| 2023 | 9 | 20 |
| 2024 | 8 | 12 |
| 2025 | 12 | 9 |
| 2026 | 9 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compounds and methods of inhibiting bacterial chaperonin systems29 Sep 2026US 12,747,219 B2Arizona Board of Regents on Behalf of the University of Arizona
- Adamantanyl-substituted benzamide compounds and their use as P2X7 receptor antagonists30 Jun 2026US 12,668,568 B2The University of Sydney
- Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium9 Jun 2026US 12,649,824 B2Resonac Corporation
- Resorcinol-based compounds and uses thereof28 Apr 2026US 12,612,358 B2Organix, Inc.
- Bioactive phenolate ionic complexes21 Apr 2026US 12,606,536 B2Hadasit Medical Research Services and Development Ltd.
- Novel mitofusin inhibitors17 Sep 2026US 2026/0274810 A1Albert Einstein College of Medicine
- Polycyclic thyroid hormone b receptor agonist and use thereof19 Feb 2026US 2026/0048060 A1Cascade Pharmaceuticals, Inc.
- N-[8-(2-hydroxybenzoyl)amino]potassium octanoate crystal polymorph, and preparation method therefor and use thereof27 Nov 2025US 2025/0361201 A1Sciwind Biosciences Co., Ltd.
- Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium13 Nov 2025US 2025/0349317 A1Resonac Corporation
- N,n'-diphenyl-4,4'-biphenyldicarboxamide analogs and their use in cancer treatment18 Sep 2025US 2025/0289780 A1
Most cited
By later US patents
- Diketopiperazine-based delivery systems228US 5,976,569 AEmisphere Technologies, Inc. · 1999
- Oral drug delivery compositions and methods186US 5,792,451 AEmisphere Technologies, Inc. · 1998
- Compounds and compositions for delivering active agents184US 5,643,957 AEmisphere Technologies, Inc. · 1997
- Carbon-substituted diketopiperazine delivery systems183US 6,331,318 B1Emisphere Technologies, Inc. · 2001
- Modified amino acids for drug delivery174US 5,629,020 AEmisphere Technologies, Inc. · 1997